KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Equity (2019 - 2025)

Vir Biotechnology (VIR) has disclosed Return on Equity for 7 consecutive years, with 0.56% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 12.0% to 0.56% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.56% through Dec 2025, down 12.0% year-over-year, with the annual reading at 0.46% for FY2025, 8.0% down from the prior year.
  • Return on Equity hit 0.56% in Q4 2025 for Vir Biotechnology, up from 0.57% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.71% in Q1 2022 to a low of 0.57% in Q3 2025.
  • Historically, Return on Equity has averaged 0.16% across 5 years, with a median of 0.34% in 2023.
  • Biggest five-year swings in Return on Equity: skyrocketed 128bps in 2022 and later plummeted -90bps in 2023.
  • Year by year, Return on Equity stood at 0.46% in 2021, then plummeted by -47bps to 0.24% in 2022, then tumbled by -254bps to 0.38% in 2023, then dropped by -16bps to 0.44% in 2024, then decreased by -29bps to 0.56% in 2025.
  • Business Quant data shows Return on Equity for VIR at 0.56% in Q4 2025, 0.57% in Q3 2025, and 0.55% in Q2 2025.